Increased serine synthesis or uptake of exogenous serine from the tumor environment by solute carrier family 1 member 4 (SLC1A4) and solute carrier family 7 member 5 (SLC7A5) is necessary for therapy resistance in many cancers [42]. The gene discussed is SLC5A7; the disease is cancer.